Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Clemons

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Bone Marrow Transplantation|August 24, 1999
Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin's lymphomaS M Lee, W D Ryder, M J Clemons, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 17, 2012
Are Estring® and Vagifem® equally effective and safe for the treatment of urogenital atrophy in breast cancer patients on aromatase inhibitor therapy?C E Simmons, I Kuchuk, O C Freedman, et al.
British Journal of Cancer|June 28, 2002
Heterogeneity of O6-alkylguanine DNA-alkyltransferase expression in human breast tumoursM J Clemons, M C Bibby, H El Teraifi, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2001
Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma GroupI Judson, J A Radford, M Harris, et al.
Blood|August 26, 1998
A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapyM J Clemons, E Marshall, J Dürig, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Bone Marrow Transplantation|August 24, 1999
Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin's lymphomaS M Lee, W D Ryder, M J Clemons, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 17, 2012
Are Estring® and Vagifem® equally effective and safe for the treatment of urogenital atrophy in breast cancer patients on aromatase inhibitor therapy?C E Simmons, I Kuchuk, O C Freedman, et al.
British Journal of Cancer|June 28, 2002
Heterogeneity of O6-alkylguanine DNA-alkyltransferase expression in human breast tumoursM J Clemons, M C Bibby, H El Teraifi, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2001
Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma GroupI Judson, J A Radford, M Harris, et al.
Blood|August 26, 1998
A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapyM J Clemons, E Marshall, J Dürig, et al.
Pageof 2